Member Info for Vanilla

I think if the boss of apple comes out with a very similar sounding statement below we can have a bit of sympathy for cpx and AK. Hopefully being much smaller and more nimble CPX's fortunes will turn round sooner as they navigate through this difficult period. The company hasn't become bad because of what is going on around it.

The update came as many firms warn about a sharp economic slowdown, especially in the tech sector which boomed during the pandemic.

Apple boss Tim Cook said the firm was navigating a "challenging environment".

He blamed the sales decline on supply shortages due to Covid-19 disruption in China - where its phones are manufactured - and a strong dollar, as well as wider economic weakness stemming from rising prices, the war in Ukraine and lingering effects from the pandemic.

Yep 56m but I think it's telling how in their last update they mention 200m raised in addition to loans taken out and looking to slash costs by 30%.

Sets up for a takeover with an initial payment at least what has been invested and further payments on achieving full accreditation to a level that will satisfy existing major shareholders. 60p now and a further 60p following accreditation or thereabouts.

Still an absolute giveaway but if a major player with all the manufacturing and global sales/support infrastructure gets hold of this at least it has a chance of commercial success that it really deserves. A much better outcome than what some negative people seem to wish upon this company.

I wouldn't say that PR it's fair to say the cpx sales team are crap infact totally **** is probably a better description and the accuracy of comms leaves a lot to be desired.
But their technology especially prizmatic is world leading and the IP has resulted in securing other products. So inspite of themselves at some point with the wide scale adoption of supercapacitors success will land on their doorstep. I would suggest as part of their cost cutting process to get rid of a few sales directors.

Good luck BB I feel torn at this price but won't be adding. I have a lot invested here at a large loss that will be corrected with the values I have in mind. Whilst a large purchase at this level would boost my profits if it turns out that way, it could still all go tits up so I will now sit and wait having bought my last lot at around 22p but I really can't see that machine ending up in the scrap heap. A competitor to Siemens/Varian would be desperate to get hold of this technology and it wouldn't be for less the 300m

From a low of 20p when I became aware of avct x500 is only £100 a share.
Cheaper the ex China £200

Good luck with all your efforts don't want to put anyone off but I have a substantial holding but won't be joining.

I'm of the MIKECC opinion complete waste of time what the BoD say but one day because of the technology cpx will land on its feet with a juggernaut sized deal that they probably didn't even see coming. Sales wise they are a very dubious outfit how long can you get away with boasting 60m pipeline and achieve derisory sales figures is not good. It's all basic sales stuff you wouldn't survive in most companies if that's how you qualify opportunities.
Don't want to be too negative as I've said not impressed with the so called sales people at cpx (taking murata orders is not selling btw) but the technology stands out and the market is moving in the right direction not withstanding the current turmoil and when the two collide by accident the shareholders will get their rewards.

Meant sense as well what an effort this has been. Anyway hopefully this turns around soon. How they go about securing these funds is going to be a real eye opener. A 50m mcap company raising 75m to 85m.
The reality is the sp should be at around 60p mcap 300m with 50m raised no problem and 25m loan and fighting off bids as 500m to 1b mcap is where it should be.
The only reason this hasn't been snapped up I believe is because the major shareholders have been loyal holders for many years at a much higher price and won't agree to a giveaway sale. If financially all falls into place I'll take that as a massive vote of confidence even with the expected dilution.

For some reason doesn't like the phrase directors talk interviews as all one word

***************************

Just replace the asterisk with above

https://www.***************************/advanced-oncotherapy-expected-to-disrupt-the-market-says-hardman-co-lonavo/4121102571

Accepting the fact hardman are slightly biased in their opinion this article makes a lot of sence to the potential value of avo & also mentions the option of a takeover that a few here feel is the way forwards.

Totally agree MCC & JT91 very relevant opinions. Most of my disappointment and frustration stems from this year being the transformational year after holding for many years. As annoying as it is will just have to reset timescales for what may well be a 24month turnaround. That said things can change very quickly and it will be out of the blue but a significant deal could land at any moment. Justifiable finger pointing at the BoD but in hindsight is it really surprising with all the known global issues at present. Whilst the BoD appeared blind to it from early comms let's hope they are equally as blind to any big deals coming there way so they can drop that bombshell news on us as well....I wish!

Very true JH where have they all come from no action for months then loads of panick sells and mysteriously a load of buyers appear. Think I'll calmly wait until July to make any decision and not worry about what is a global situation affecting markets.

Be interesting to see what happens to the 14p broker and simply wall st 24p valuations.
Anyone here have a view on the inverse correlation between the order book and actual sales. One keeps growing whilst the other falls, am I missing something or are they continuing to receive orders but just not able to ship as many products into sales for the reasons highlighted.
Anyway still holding waiting for better fortunes need some serious patience in this market.

Should read good luck, hopefully we won't need it!

July was the last date I was aware of from document below:

SO ORDERED, re [207] PROPOSED ORDER Second Amended Scheduling Order: (Fact Discovery completed by 1/20/2023., Dispositive Motions due by 3/24/2023., Answering Brief due 4/7/2023., Reply Brief due 4/21/2023., A Final Pretrial Conference is set for 7/13/2023 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly., A Jury Trial is set for 7/24/2023 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly.) Signed by Judge Colm F. Connolly on 11/3/2022.

BB you're probably correct retail investors have been selling out for many years and this collapse in the sp will make many more give up. I was actually tempted to buy more at this level which would give me a very good average but having done so already in the low 20's I'm going to stick with what I have. Never sold any of these and sitting on a large £ loss at present but I just can't see a technology like this not coming to market. I expect either a low price takeover or further progress as an independent with all the dilution will still result in a much higher sp that may just return me a profit. The ironic thing is that if they had delivered 230MeV back when they had the original Chinese orders this news would of achieved a much more positive reaction and significant value. With all the changes to previously communicated plans much of the market doesn't have confidence in the latest road map to commercialisation. Obviously signed orders, successful patient treatment, achieving accreditation and £10's of millions of pounds in the bank will build confidence, as would a takeover by a major but that would be it for any sp growth. The fact II's like OAM have made recent significant investments is reassuring and I hope we don't get news of any large sell-off as that would seriously erode what little confidence remains. Good look anyway and hopefully we soon hear news of further progress in what really is an amazing technological achievement and a world's first that unfortunately hasn't received the credit it deserves. When it does like you say we could get a substantial upturn.

The one thing markets don't like is uncertainty which is in abundance here. When the financial arrangements are announced that bit of uncertainty will be removed.

The questions regarding manufacturing will probably remain as I never thought Daresbury was capable of the required high volume that was proposed with Thales. It seems more of an assembly and test facility that is now advanced into a medical facility providing patient treatment.

This is one of the main reasons a buy-out makes sense, if the order book fills up to anywhere near the 20 prospects in the pipeline they just don't have the resources to deliver these systems. Might not happen until the accreditation process has completed but as long as progress continues with funding, patient treatment and commercial deals the value of what they will have achieved is much more than the current sp. Looks like a volatile few months ahead but a very good chance of a good outcome whichever way it ends up.

I'm hoping this share does what ARB did. Back in December it was 2.5p and seemed a hopeless case now at 16p. I'm not invested in ARB or anything else to do with crypto but have kept a watchful eye and it goes to show how large the swings can be on positive news in AIM.

A similar turn around here would see this at around 60p and a mc of around 300m which is not a lot considering what they have developed and the cost to get to this point.
This could end up with around 1B shares in issue with existing warrants and if they secure dilutive funding of around £40m of the required £85m. The mc will then be dependent on commercial success following accreditation.

Having been invested for many years and reduced my average I wouldn't be disappointed with a 60p buy-out but if they achieve commercial success it's easy to see this being worth much more.

Have to say pre 230MeV I was of the take over opinion for the many reasons quoted by shareholders on this BB. Having seen what they have achieved I was having a change of mind but it looks like the market has the memory of an elephant and this sp will make things very difficult to get to full commercialisation as an independent company.
With companies like Siemens paying $16B for Varian there will be pressure to protect their market share. Paying between $500m & $1B to secure a disruptive technology in a market you have already made a substantial investment in will be a consideration to some large players.
Not sure some of the larger avo shareholders would be happy with around £1 a share but many here me included would definitely feel a sigh of relief putting an end to what feels like never ending uncertainty. However it plays out this low sp seems to be a real bargain let's hope if there is a takeover it's at a much higher price.

I don't believe anything has changed regarding the status of existing orders for Limassol Cyprus, Glion Switzerland and Harley Street in London which were mentioned in the recent Hardman & Co report.
Until binding contracts are signed which will hopefully happen prior to full accreditation and additional funds become available to commence manufacturing of these systems not much will be happening with the focus on raising funds and continuing the work towards first patient treatment as detailed in today's rns.